Peripheral Artery Disease (PAD)

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effect of Beetroot Juice on Coronary Blood Flow and Walking Performance in PAD

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Beetroot juice;   Drug: Beetroot juice placebo
Sponsors:   David N. Proctor, PhD;   Milton S. Hershey Medical Center;   Wake Forest University Health Sciences

BIOTRONIK 4French for AMBulatory Peripheral Intervention

Conditions:   Peripheral Artery Disease;   Access Site Complication;   Outpatient Treatment
Interventions:   Device: Biotronik 4 French Portfolio;   Device: 6 French Portfolio
Sponsor:   Biotronik AG

Community Walking Exercise for Patients With Peripheral Artery Disease

Condition:   Peripheral Artery Disease
Interventions:   Behavioral: Exercise therapy;   Procedure: lower extremity ET;   Procedure: peripheral open intervention
Sponsors:   University of Minnesota;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)

Condition:   Peripheral Arterial Disease
Intervention:   Device: MicroStent
Sponsor:   Micro Medical Solution, Inc.
Active, not recruiting

Static Muscular Stretching for Treatment of PAD

Condition:   Peripheral Artery Disease
Intervention:   Device: Ankle Splint
Sponsors:   Florida State University;   Mayo Clinic
Not yet recruiting

Ischemic Preconditioning Claudication Study

Conditions:   Intermittent Claudication;   Ischemia Vascular;   Peripheral Arterial Disease;   Peripheral Vascular Disease
Interventions:   Other: Ischemic Preconditioning;   Other: Control Group
Sponsor:   Medical College of Wisconsin
Active, not recruiting

Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study

Conditions:   Diabetic Foot Ulcer;   Offloading
Intervention:   Device: Offloading boot : PulseFlow
Sponsors:   Baylor College of Medicine;   The Diabetic Boot Company

High Intensity Interval Training In pATiEnts With Intermittent Claudication

Conditions:   Peripheral Arterial Disease;   Intermittent Claudication
Intervention:   Other: High-intensity interval training
Sponsors:   Hull University Teaching Hospitals NHS Trust;   University of Hull

Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)

Condition:   Peripheral Arterial Disease
Interventions:   Behavioral: Supervised Treadmill Exercise Therapy;   Other: Health education sessions (Control);   Drug: granulocyte macrophage colony stimulating factor (GM-CSF)
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)

Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis

Conditions:   Vascular Diseases;   Peripheral Vascular Disease;   Surgical Site Infection;   Bypass Complication
Intervention:   Drug: Topical Anti Infective Agents
Sponsor:   Lawson Health Research Institute
Not yet recruiting

New Oxymetry Indices in Critical Limb Ischemia

Condition:   Critical Limb Ischemia
Intervention:   Diagnostic Test: transcutaneous oximetry
Sponsor:   University Hospital, Angers

HemaTrate™ in the Treatment of Critical Limb Ischemia

Conditions:   Critical Limb Ischemia;   Ischemia
Interventions:   Device: HemaTrate™ Blood Filtration system;   Other: Saline
Sponsor:   Cook Research Incorporated

AVAZZIA Electrical Stimulation

Conditions:   Diabetes;   Diabetic Foot Ulcer;   Peripheral Neuropathy;   Peripheral Arterial Disease
Interventions:   Device: Electrical Stimulation;   Device: Electrical Stimulation - Sham
Sponsors:   Baylor College of Medicine;   Avazzia, Inc;   Brian Lepow, DPM

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Condition:   Critical Limb Ischemia
Interventions:   Drug: Apixaban;   Drug: ASA;   Drug: Clopidogrel 75mg
Sponsors:   Science Valley Research Institute;   Wyeth is now a wholly owned subsidiary of Pfizer